Language Spoken : English & Arabic
Dr. Ibrahim Husni Abu-Gheida is an Attending Radiation Oncology Physician at Burjeel Medical City, Abu-Dhabi. Dr. Abu-Gheida trained at world-leading academic cancer institutions including the American University of Beirut Medical Centre, Cleveland Clinic/Ohio, and the University of Texas MD Anderson Cancer Center; which is ranked as the number-one cancer center in the United-States.
Dr. Abu-Gheida is licensed to treat all sites that require radiation therapy for malignant, benign, or functional diseases. He is mainly interested in providing the most up-to-date, evidence-based, and individualized care to patients. Dr. Abu-Gheida’s philosophy remains to evaluate and treat each patient as his own family member, therefore providing every patient with the best quality of care they deserve. Dr. Abu-Gheida has a special interest in treating breast, gastrointestinal, Genito-urinary, thoracic, and Central-nervous-system diseases, as well as benign and functional diseases amenable to radiotherapy.
Providing efficient and cost-effective therapy for patients that maintain the best outcome and quality of life for the patient is a special area of interest for Dr. Abu-Gheida. Dr. Abu-Gheida currently serves as a member of Burjeel hospital Institutional Review Board (IRB) that monitors and governs research in the institution.
Qualifications Advanced Clinical Radiation Oncology Fellow-The University of Texas MD Anderson Cancer Center, Houston, Texas the USA Advanced Clinical Radiation Oncology Fellow- Cleveland Clinic Foundation, Ohio, USA. Radiation Oncology Residency – The American University of Beirut Medical Center, Beirut, Lebanon Doctor of Medicine – The American University of Beirut faculty of medicine and medical center. USA Education Commission for Foreign Medical Graduate Certified Bachelor of Science – Biology Major. The American University of Beirut Faculty of arts and sciences. The American University of Beirut and the American University of Beirut Medical Center. Beirut – Lebanon. Harvard University-affiliated NIH- Funded Scholar in Health Research Program (SHARP) Certificate. Full Scholarship diploma in a 7-week intensive clinical research-training program to provide superior didactic education with interactive and practical training in health research (namely epidemiology, biostatistics, research ethics, library sciences, informatics, and hands-on training analyzing and reporting large data sets). Intended for health care professionals who seek to advance the research agenda in non-communicable diseases. Professional Memberships Member of VPS/Burjeel Hospital Institutional Review Board (IRB) Committee Member of the American Society of Radiation Oncology Member of the American Society of Clinical Oncology Achievements & Certifications He got his Doctor of Medicine (MD) degree from the American University of Beirut in 2012. Then he acquired his Internal Medicine and Radiation Oncology Residency at the American University of Beirut Medical Center in where he was the chief resident in 2017. Following that Dr. Abu-Gheida got his clinical fellowship in the advanced radiation oncology department from Cleveland Clinic Ohio, USA, in 2018. Dr. Abu-Gheida got his second clinical fellowship in advanced radiation oncology from the University of Texas, MD Anderson Cancer Center, Huston, Texas, USA. Research & Publications Selected Publications: Elhalwani H, Awan M, Ding Y, Mohamed A, Elsayes A, Abu-Gheida I , Wang J, Hazle J, Gunn GB, Lai S, Frank S, Ginsberg L, Rosenthal D, Fuller C. Data from a terminated study on iron oxide nanoparticle magnetic resonance imaging for head and neck tumors. Accepted Manuscript, Nature Scientific Data. Dec 2019
Geara FB, Abu Gheida I , Asmar K, Youssef B, Sabri A, Tfayli A, Shamseddine A. Impact of chemotherapy response on the outcome of Nasopharyngeal Cancer Treated by Induction Chemotherapy and Definitive Radiation. Arch Onco Resh Ther. Nov2019 Abu-Gheida I , Hammoudeh L, Abdel- Razeq H. Controversies of radiation therapy omission in elderly women with early-stage invasive breast cancer. Transl Cancer Res 2019 Jul 2019
Abu-Gheida I , Chao S, Murphy E, Suh J, Stevens, GH, Mohammadi A, McNamara M, Yu JS. Targeted therapy after brain radiotherapy for BRAF-mutated melanoma with an extensive ependymal disease with prolonged survival: Case report and review of the literature Front Oncol. 2019 PMID: 30972290 Mar 2019
Abu-Gheida I, Reddy CA, Kotecha R, Shah CS, Kupelian PA, Mian OY, Ceizki JP, Stephans KL Tendulkar RD; Ten-Year Outcomes and Toxicity with Moderately hypofractionated (70 Gy in 28 fractions) Intensity-Modulated Radiation Therapy for Localized Prostate Cancer. Intern J Radio Onc Biol Phys PMID: 30721720 Feb2019 Abu-Gheida I , Fleming C, Ramia P, Mian O, Tendulkar RT, Ceizki J. Current controversies in prostate brachytherapy for prostate cancer. Applied Radiation Oncology . P6-11 Sep 2017
Refaat MM, Ballout JA, Zakka P, Hotait M, Al Feghali KA, Abu Gheida I , Saade C, Hourani M, Geara F, Tabbal M, Sfier P, Jalbout W, Al-Jaroudi W, Jurjus A, Youssef B. Swine Atrioventricular Node Ablation using stereotactic radiosurgery: methods and in vivo feasibility investigation for catheter-free ablation of cardiac arrhythmias. J Am Heart Assoc. PMID: 29079566 Sep 2017
Geara FB, Bulbul M, Khauli RB, Andraos TY, Abboud M, Al Mousa A, Sarhan N, Salem A, Ghatasheh H, Alnsour A, Ayoub Z, Abu Gheida I , Charafeddine M, Shahait M, Shamseddine A, Abou Ghaida R, Khader J. Nadir PSA is a strong predictor of treatment outcome in intermediate and high risk localized prostate cancer patients tread by definitive external beam radiotherapy and androgen deprivation. Radiat. Oncol. PMID: 28882187 Sep 2017
Hilal L, Al Feghali K, Ramia P, Abu Gheida I , Obeid JP, Jalbout W, Youssef B, Geara F, Zeidan Y. Intraoperative Radiation Therapy: A Promising Treatment Modality in Head and Neck Cancer. Front. Oncol PMID: 28736725 Jul 2017
Abu-Gheida I , Deeba S, Zouain N. Recurrent Low Rectal Cancer in a Non-Surgical Patient: Case Report of the First Multi-Channel Endorectal Brachytherapy Use in Lebanon. World Journal of Colorectal Surgery . ue 2 Apr 2016
Temraz S, Mukherji D, Ferhat Z, Nasr R, Charafeddine M, Shahait M, Wehbe M, Ghaida R, Abu –Gheida I , Shamseddine A. Preoperative lymphocyte to monocyte ratio predicts clinical outcome in patients undergoing radical cystectomy for transitional cell carcinoma of the bladder: a retrospective analysis. BMC Urol PMID: 25234356 Sep 2014
Selected Peer-Reviewed Abstracts and Presentations: Bahig H, Colbert L, Mitra A, Solley T, Medrano AYD, Ng SP, Abu-Gheida I , Rosenthal DI, Elgohari B, Fuller CD, Klopp AH. Characterization of the Oropharyngeal Microbiome during Radiotherapy in HPV-Associated Oropharynx Cancer. Intern J Radio Onc Biol Phys Abu-Gheida I , Patel A, Zaid M Elganainy D, Javle M, Kanwal R, Vauthey JN, Aloia TA, Tzeng CW, Minsky B, Smith GL, Holliday EB, Taniguchi CM, Koong AC, Krishnan S, Herman J, Das P, Crane CH, Koay EJ. Outcomes and patterns of failures after hypofractionated radiation therapy for intrahepatic cholangiocarcinoma (J Clin Oncol 37,2019. supple; abstr e-15609)
Abu-Gheida I , Strom EA, Smith BD, Hoffman K, Reddy JP, Tereffe W, Shaitelman SF, Perkins GH, Stauder M, Howell R, Salehpour M, Woodward WA. Breath management strategies dramatically reduce irradiated lung volumes when used for comprehensive right-sided breast cancer radiation: analysis from the University of Texas MD Anderson experience. (Poster MDACC 2019 GAP conference – Manuscript pending final review ). Mian OY, Abu-Gheida I , Kotecha R, Weller, MA, Reddy CA, Kupelian P, Ornstein MC, Gilligan TD, Carcia JA, Rini BI, Stephenson AJ, Klein EA, Shah C, Ciezky JP, Stephans KL, Tendulkar RD. Moderately hypofractionated radiotherapy for localized prostate cancer: Long-term outcomes for 854 consecutive patients treated over 10 years (70 Gy in 2.5 Gy/Fraction). (Journal of Clinical Oncology 2019 37:7_suppl 78-78.) Ramia P, Hilal L, Geara FB, Jalbout, W, Zakka P, Ballout, J Hotait, Abu Gheida I , Al Feghali K, Eid TA, Refaat M, Youssef BY. Stereotactic Radiosurgery for Atrioventricular Node Ablation in Swine: A Study on Efficacy and Dosimetric Evaluation of Organs at Risk. TU_13_3019 Intern J Radio Onc Biol Phys Sep 2019
Jun 2019
Mar 2019
Jan 2019
Oct 2018
Abu-Gheida I, Kotecha R, Shah CS, Reddy CA, Kupelian PA, Mian OY, Ceizki JP, Stephans KL Tendulkar RD; Ten-Year Outcomes and Toxicity with Moderately hypofractionated (70 Gy in 28 fractions) Intensity-Modulated Radiation Therapy for Localized Prostate Cancer. Accepted ASTRO Oral Presentation Abstract 63 (24072) Intern J Radio Onc Biol Phys Oct 2018
Abu-Gheida I, Alzaghal A, Naffaa L, Taddei P. Total Body MRI-Based Distribution of Active Bone Marrow in Young Children. Abstract # 3340. Inter. J Radio Onc Biol Phys V 99 E563 Oct 2017
Abu Gheida I , Hilal L, Sukhon F, Najjar M Skaf G, Geara FB, Charafeddine M, Medlej Y, Haddadin F, Assi H. Demographics and Outcome of Meningioma Patients treated at a Tertiary Care Center in the Middle East. Poster at the 5th Quadrennial Meeting of World Federation of Neuro-Oncology Societies , Zurich SwitzerlandMay 2017
Abu-Gheida I, Mekdash H, Charafeddine M, Youssef B, Shahine B, Geara FG. Is Intesity Modulated Radiotherapy Always Superior to 3D Radiation Therapy to Treat Prostate Cancer? A Study Based on Normal Tissue Constraints and Individual Patient Anatomy. Oral Presentation at the MDACC/AUBMC/KHCC connecting through research conference. Beirut, Lebanon May 2017
Geara FB, Abu-Gheida I, Abboud M, Asmar K, Eid T, Youssef B, Salem Z, Sabri A, Shamseddine A, Tfayli A. Nasopharyngeal Cancer Treated by Induction Chemotherapy and Definitive Radiation: Impact of Chemotherapy response on outcome. Oral Presentation at the Annual University of Texas MD Anderson GAP conference Apr 2013
Reviewer: The American Urological Association Urology Practice Journal May 2019
Book Chapters: Abu-Gheida I , Sittenfeld S, Chao S, and Suh J. Interstitial brachytherapy treatment for oligodendroglioma In Paleologos NA and Newton HB, (eds). oligodendroglioma: Clinical Presentation, Pathology Molecular Biology, Imaging, and Treatment . San Diego: Elsevier Inc./Academic Press, 2019: 287-298.
Clinical Expertise & Services Breast Gastro – intestinal Genitourinary Thoracic Central nervous system tumors Benign and functional diseases 
